Company
United StatesPublic company, NASDAQ: IMNMImmunome, Inc. (NASDAQ: IMNM), Bothell, WA – FDA Inspections
Inspection records and compliance data for Immunome, Inc. in Bothell, WA. 1 FDA inspection on record, last inspected August 13, 2026. Publicly traded as NASDAQ: IMNM.
Company Profile
This profile covers Immunome, Inc. based in Bothell, WA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 13, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 13, 2026 | Not classified | Human Drugs | 1335214 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (8)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Immunome, Inc.
Stock ticker
IMNM
Exchange
NASDAQ
Share price
$18.70
Market cap
$2.2B
Price as of
November 13, 2026
FEI Number
3031226402
Address
18702 N Creek Pkwy, Bothell, WA 98011-8019, United States
Country
United States
ID: 7305e769-28d0-4e61-b3e9-48be655cdcc4